A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Moexipril hydrochloride | Moexipril hydrochloride (RS-10085) is an orally active inhibitor of angiotensin-converting enzyme ( ACE ), and becomes effective by being hydrolyzed to moexiprila (hydrochloride). Moexipril hydrochloride exhibits antihypertensive and neuroprotective effects [1] - [4]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: RS-10085. CAS No. 82586-52-5. Pack Sizes: 10 mM * 1 mL; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-B0378A. |  |
| Moexipril Hydrochloride ((3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenyl-d5-propyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic Acid Hydrochloride, CI-925, RS-10085-197, SPM-925, Fempress, Perdix, Univasc) | Angiotensin converting enzyme (ACE) inhibitor; dimethoxy analog of quinapril. Group: Biochemicals. Alternative Names: (3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenyl-d5-propyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic Acid Hydrochloride; CI-925; RS-10085-197; SPM-925; Fempress; Perdix; Univasc. Grades: Highly Purified. CAS No. 82586-52-5. Pack Sizes: 10mg. US Biological Life Sciences. |  Worldwide |
| Moexipril Methyl Benzyl Ester Maleate | Moexipril derivative. Group: Biochemicals. Alternative Names: [3S-[2-(S),3S]]-1,2,3,4-Tetrahydro-6,7-dimethoxy-2-[2-[[1-(methoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-3-isoquinolinecarboxylic Acid Benzyl Ester Maleate. Grades: Highly Purified. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Moexipril Methyl Ester Analog Hydrochloride Salt | An impurity of Moexipril. Group: Biochemicals. Alternative Names: [3S-[2-(S),3S]]-1,2,3,4-Tetrahydro-6,7-dimethoxy-2-[2-[[1-(methoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-3-isoquinolinecarboxylic Acid Hydrochloride. Grades: Highly Purified. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Moexipril Related Compound A | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. |  |
| Moexipril Related Compound B | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Moexipril Related Compound C | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Moexipril Related Compound D | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Moexipril Related Compound E | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Moexipril Related Compound F | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Moexipril Related Compound G | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Moexipril tert-Butyl Ester Maleic Acid Salt | An impurity of Moexipril. Group: Biochemicals. Alternative Names: (3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic Acid 1,1-Dimethylethyl Ester; (2Z)-2-Butenedioate. Grades: Highly Purified. CAS No. 103733-40-0. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| MOF | MOF. Group: Carboxylic acid nitrogen-containing mixed mof ligand-multiple mixed ligand. Molecular formula: white powder. |  |
| MOF&1,1',1'',1'''-ethene-1,1,2,2-tetrayltetrakis(4-methylbenzene) | MOF&1,1',1'',1'''-ethene-1,1,2,2-tetrayltetrakis(4-methylbenzene). Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-tetra-substituted tpe. Pack Sizes: 10 mg. | |
| MOF&1,1':2',1''-Terphenyl, 4,4''-dibromo-3',4',5',6'-tetrakis(4-bromophenyl)- | MOF&1,1':2',1''-Terphenyl, 4,4''-dibromo-3',4',5',6'-tetrakis(4-bromophenyl)-. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-triphenylbenzene. Pack Sizes: 20 mg. | |
| MOF&1,1',2,2'-tetrakis(4-bromophenyl)ethene | MOF&1,1',2,2'-tetrakis(4-bromophenyl)ethene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-tetra-substituted tpe. Pack Sizes: 50 mg. | |
| MOF&1,1,2-Triphenyl-2-(4- bromomethylphenyl)ethylene | MOF&1,1,2-Triphenyl-2-(4- bromomethylphenyl)ethylene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-1-substituted tpe. Pack Sizes: 10 mg. | |
| MOF&1, 1'-(5'-(4-acetylphenyl)-[1, 1':3', 1''-terphenyl]-4, 4''-diyl)diethanone | MOF&1, 1'-(5'-(4-acetylphenyl)-[1, 1':3', 1''-terphenyl]-4, 4''-diyl)diethanone. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-triphenylbenzene. Pack Sizes: 50 mg. | |
| MOF&[1, 1'-Binaphthalene]-2, 2'-diamine | MOF&[1, 1'-Binaphthalene]-2, 2'-diamine. Group: Organic-linker blocks- other linker blocks. Pack Sizes: 10mL. Product ID: 1-(2-aminonaphthalen-1-yl)naphthalen-2-amine. Molecular formula: 284.4g/mol. Mole weight: C20H16N2. InChI=1S / C20H16N2 / c21-17-11-9-13-5-1-3-7-15 (13) 19 (17) 20-16-8-4-2-6-14 (16) 10-12-18 (20) 22 / h1-12H, 21-22H2. DDAPSNKEOHDLKB-UHFFFAOYSA-N. | |
| MOF&[1,1-bis(4-N,N-dimethylphenyl)-2,2-bis(4-bromophenyl)]ethylene | MOF&[1,1-bis(4-N,N-dimethylphenyl)-2,2-bis(4-bromophenyl)]ethylene. Group: Organic-linker blocks-bi-substituted tpe. | |
| MOF&1,1-diphenyl-2,2-di(4-bromomethyl-phenyl)ethylene | MOF&1,1-diphenyl-2,2-di(4-bromomethyl-phenyl)ethylene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-1-substituted tpe. Pack Sizes: 20 mg. | |
| MOF&1,1-diphenyl-2,2-di(p-bromophenyl)ethylene | MOF&1,1-diphenyl-2,2-di(p-bromophenyl)ethylene. Group: Organic-linker blocks-bi-substituted tpe. Pack Sizes: Customized service. | |
| MOF&1,2-Benzenedicarbonitrile, 4,5-diamino- | MOF&1,2-Benzenedicarbonitrile, 4,5-diamino-. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks- other linker blocks. Pack Sizes: 20 mg. | |
| MOF&1,2-Bis[4-(bromomethyl)phenyl]-1,2-diphenylethene | MOF&1,2-Bis[4-(bromomethyl)phenyl]-1,2-diphenylethene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-bi-substituted tpe. Pack Sizes: 10 mg. Product ID: 1-(bromomethyl)-4-[(E)-2-[4-(bromomethyl)phenyl]-1,2-diphenylethenyl]benzene. Molecular formula: 518.3g/mol. Mole weight: C28H22Br2. InChI=1S / C28H22Br2 / c29-19-21-11-15-25 (16-12-21) 27 (23-7-3-1-4-8-23) 28 (24-9-5-2-6-10-24) 26-17-13-22 (20-30) 14-18-26 / h1-18H, 19-20H2 / b28-27+. GHZTXESUSOBGAM-BYYHNAKLSA-N. | |
| MOF&1,2-Bis(4-bromophenyl)-1,2-diphenylethene | MOF&1,2-Bis(4-bromophenyl)-1,2-diphenylethene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-bi-substituted tpe. Pack Sizes: 10 mg. Product ID: 1-bromo-4-[(E)-2-(4-bromophenyl)-1,2-diphenylethenyl]benzene. Molecular formula: 490.2g/mol. Mole weight: C26H18Br2. InChI=1S/C26H18Br2/c27-23-15-11-21 (12-16-23)25 (19-7-3-1-4-8-19)26 (20-9-5-2-6-10-20)22-13-17-24 (28)18-14-22/h1-18H/b26-25+. BBSNJTOHVHUCRF-OCEACIFDSA-N. | |
| MOF&1,2-Bis(4-hydroxyphenyl)-1,2-diphenylethylene | MOF&1,2-Bis(4-hydroxyphenyl)-1,2-diphenylethylene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-bi-substituted tpe. Pack Sizes: 10 mg. | |
| MOF&1,2-di-[4-(aminomethyl)phenyl]-1,2-diphenylethylene | MOF&1,2-di-[4-(aminomethyl)phenyl]-1,2-diphenylethylene. Group: Organic-linker blocks-bi-substituted tpe. | |
| MOF&1,2-Di(4-carboxyphenyl)-1,2,2-triphenylethene | MOF&1,2-Di(4-carboxyphenyl)-1,2,2-triphenylethene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Carboxylic acid mof ligand-dicarboxylic acid mof ligand. Pack Sizes: 20 mg. | |
| MOF&[1,2-diphenyl-1,2-bis(4-cyanophenyl)ethylene | MOF&[1,2-diphenyl-1,2-bis(4-cyanophenyl)ethylene. Group: Organic-linker blocks-bi-substituted tpe. Pack Sizes: 10mL. | |
| MOF&1,2-Ethanediamine, N,N-bis(2-pyridinylmethyl)- | MOF&1,2-Ethanediamine, N,N-bis(2-pyridinylmethyl)-. Group: Organic-linker blocks- other linker blocks. | |
| MOF&1-(2-Propyn-1-yloxy)-4-(1,2,2-triphenylethenyl)benzene | MOF&1-(2-Propyn-1-yloxy)-4-(1,2,2-triphenylethenyl)benzene. Uses: Composite materials, bio-labeling, optoelectronic devices, fluorescence materials etc. Group: Organic-linker blocks-1-substituted tpe. Pack Sizes: 50 ml. | |
| MOF&1,3,2-Dioxaborolane, 2,2'-[(1,2-diphenyl-1,2-ethenediyl)di-4,1-phenylene]bis[4,4,5,5-tetramethyl- | MOF&1,3,2-Dioxaborolane, 2,2'-[(1,2-diphenyl-1,2-ethenediyl)di-4,1-phenylene]bis[4,4,5,5-tetramethyl-. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-bi-substituted tpe. Pack Sizes: 10 mg. | |
| MOF&1,3,5-Triazine, 2,4,6-tris(3,5-dimethyl-1H-pyrazol-1-yl)- | MOF&1,3,5-Triazine, 2,4,6-tris(3,5-dimethyl-1H-pyrazol-1-yl)-. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Nitrogen-containing mof ligand-ternary nitrogen-containing mof ligand. CAS No. 154403-27-7. Pack Sizes: 20 mg. Product ID: 2,4,6-tris(3,5-dimethylpyrazol-1-yl)-1,3,5-triazine. Molecular formula: 363.4g/mol. Mole weight: C18H21N9. InChI=1S/C18H21N9/c1-10-7-13 (4)25 (22-10)16-19-17 (26-14 (5)8-11 (2)23-26)21-18 (20-16)27-15 (6)9-12 (3)24-27/h7-9H, 1-6H3. DGBHCVCPUCYWEM-UHFFFAOYSA-N. | |
| MOF&1,3,5-Tris(4-bromophenyl)benzene | MOF&1,3,5-Tris(4-bromophenyl)benzene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-triphenylbenzene. Pack Sizes: 10 mg. Product ID: 1,3,5-tris(4-bromophenyl)benzene. Molecular formula: 543.1g/mol. Mole weight: C24H15Br3. InChI=1S/C24H15Br3/c25-22-7-1-16 (2-8-22)19-13-20 (17-3-9-23 (26)10-4-17)15-21 (14-19)18-5-11-24 (27)12-6-18/h1-15H. HJQRITCAXSBOPC-UHFFFAOYSA-N. | |
| MOF&1,3,6,8-Tetrabromopyrene | MOF&1,3,6,8-Tetrabromopyrene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-halide substituted aromatics. Pack Sizes: 10 mg. Product ID: 1,3,6,8-tetrabromopyrene. Molecular formula: 517.8g/mol. Mole weight: C16H6Br4. InChI=1S/C16H6Br4/c17-11-5-13 (19)9-3-4-10-14 (20)6-12 (18)8-2-1-7 (11)15 (9)16 (8)10/h1-6H. ZKBKRTZIYOKNRG-UHFFFAOYSA-N. | |
| MOF&1, 3- Benzenedicarboxylic acid, 5- borono- | MOF&1, 3- Benzenedicarboxylic acid, 5- borono-. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks- isophthalate. Pack Sizes: 20 mg. | |
| MOF&1-(4-Aminophenyl)-1,2,2-triphenylethene | MOF&1-(4-Aminophenyl)-1,2,2-triphenylethene. Uses: Na. Group: Organic-linker blocks-1-substituted tpe. Pack Sizes: 100 mg. | |
| MOF&1-(4-Bromophenyl)-1,2,2-triphenylethene | MOF&1-(4-Bromophenyl)-1,2,2-triphenylethene. Group: Organic-linker blocks-1-substituted tpe. Pack Sizes: 50 ml. Product ID: 1-bromo-4-(1,2,2-triphenylethenyl)benzene. Molecular formula: 411.3g/mol. Mole weight: C26H19Br. InChI=1S/C26H19Br/c27-24-18-16-23 (17-19-24) 26 (22-14-8-3-9-15-22) 25 (20-10-4-1-5-11-20) 21-12-6-2-7-13-21/h1-19H. MYJLJYSALGARCM-UHFFFAOYSA-N. | |
| MOF&1,4-Dibromo-2,5-diiodobenzene | MOF&1,4-Dibromo-2,5-diiodobenzene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-halide substituted aromatics. Pack Sizes: 10 mg. Product ID: 1,4-dibromo-2,5-diiodobenzene. Molecular formula: 487.70g/mol. Mole weight: C6H2Br2I2. InChI=1S/C6H2Br2I2/c7-3-1-5 (9)4 (8)2-6 (3)10/h1-2H. IVKPEQAIHJWGGT-UHFFFAOYSA-N. | |
| MOF&1-(4-Hydroxyphenyl)-1,2,2-triphenylethene | MOF&1-(4-Hydroxyphenyl)-1,2,2-triphenylethene. Group: Organic-linker blocks-1-substituted tpe. | |
| MOF&1-(4-phenylboronic acid pinacol ester)-1,2,2-triphenylethene | MOF&1-(4-phenylboronic acid pinacol ester)-1,2,2-triphenylethene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-1-substituted tpe. Pack Sizes: 50 mg. | |
| MOF&1,5-dibromo-2,4-bis(bromomethyl)benzene | MOF&1,5-dibromo-2,4-bis(bromomethyl)benzene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-halide substituted aromatics. Pack Sizes: 10 mg. Product ID: 1,5-dibromo-2,4-bis(bromomethyl)benzene. Molecular formula: 421.75g/mol. Mole weight: C8H6Br4. InChI=1S/C8H6Br4/c9-3-5-1-6 (4-10)8 (12)2-7 (5)11/h1-2H, 3-4H2. UYNPUSPGNRCVLC-UHFFFAOYSA-N. | |
| MOF&1H,1'H-2,2'-Biimidazole | MOF&1H,1'H-2,2'-Biimidazole. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks- other linker blocks. Pack Sizes: 10 mg. Product ID: 2-(1H-imidazol-2-yl)-1H-imidazole. Molecular formula: 134.14g/mol. Mole weight: C6H6N4. InChI=1S/C6H6N4/c1-2-8-5 (7-1)6-9-3-4-10-6/h1-4H, (H, 7, 8) (H, 9, 10). AZUHIVLOSAPWDM-UHFFFAOYSA-N. | |
| MOF&1H- Imidazole, 1, 1', 1'', 1'''- (1, 2- ethenediylidenetetra - 4, 1- phenylene) tetrakis- | MOF&1H- Imidazole, 1, 1', 1'', 1'''- (1, 2- ethenediylidenetetra - 4, 1- phenylene) tetrakis-. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-tetra-substituted tpe. Pack Sizes: 50 mg. | |
| MOF&1-oxido-N-[(1-oxopyridin-1-ium-4-ylidene)amino]pyridin-4-imine | MOF&1-oxido-N-[(1-oxopyridin-1-ium-4-ylidene)amino]pyridin-4-imine. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks- other linker blocks. Pack Sizes: 10 mg. | |
| MOF&21H, 23H- Porphine, 5, 10, 15, 20- tetra- 1H- pyrazol- 4- yl- | MOF&21H, 23H- Porphine, 5, 10, 15, 20- tetra- 1H- pyrazol- 4- yl-. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Customizable mof linkers. Pack Sizes: 50mg. | |
| MOF&21H, 23H- Porphine, 5, 10, 15, 20- tetra- 3- pyridinyl- | MOF&21H, 23H- Porphine, 5, 10, 15, 20- tetra- 3- pyridinyl-. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Customizable mof linkers. Pack Sizes: 16 mg. | |
| MOF&2,2'-((2,2-diphenylethene-1,1-diyl)bis(4,1-phenylene))bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) | MOF&2,2'-((2,2-diphenylethene-1,1-diyl)bis(4,1-phenylene))bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane). Group: Organic-linker blocks- other linker blocks. Product ID: 2-[4-[2,2-diphenyl-1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethenyl]phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane. Molecular formula: 584.4g/mol. Mole weight: C38H42B2O4. InChI=1S/C38H42B2O4/c1-35 (2) 36 (3, 4) 42-39 (41-35) 31-23-19-29 (20-24-31) 34 (33 (27-15-11-9-12-16-27) 28-17-13-10-14-18-28) 30-21-25-32 (26-22-30) 40-43-37 (5, 6) 38 (7, 8) 44-40/h9-26H, 1-8H3. SIBUCPJWEIWPQT-UHFFFAOYSA-N. | |
| MOF&2,2':6',2''-Terpyridine,4'-(4-chlorophenyl)- | MOF&2,2':6',2''-Terpyridine,4'-(4-chlorophenyl)-. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks- other linker blocks. Pack Sizes: 10 mg. Product ID: 4-(4-chlorophenyl)-2,6-dipyridin-2-ylpyridine. Molecular formula: 343.8g/mol. Mole weight: C21H14ClN3. InChI=1S/C21H14ClN3/c22-17-9-7-15 (8-10-17)16-13-20 (18-5-1-3-11-23-18)25-21 (14-16)19-6-2-4-12-24-19/h1-14H. UPOMZZQMFGCHGB-UHFFFAOYSA-N. | |
| MOF&[2, 2'-Bipyridine]-3, 3'-dicarboxylicacid, 3,3'-dimethyl ester | MOF&[2, 2'-Bipyridine]-3, 3'-dicarboxylicacid, 3,3'-dimethyl ester. Uses: Na. Group: Organic-linker blocks- other linker blocks. Pack Sizes: 100mg. | |
| MOF&[2, 2'-Bipyridine]-3, 3'-dimethanol | MOF&[2, 2'-Bipyridine]-3, 3'-dimethanol. Group: Organic-linker blocks-bipyridine blocks. Product ID: [2-[3-(hydroxymethyl)pyridin-2-yl]pyridin-3-yl]methanol. Molecular formula: 216.24g/mol. Mole weight: C12H12N2O2. InChI=1S / C12H12N2O2 / c15-7-9-3-1-5-13-11 (9) 12-10 (8-16) 4-2-6-14-12 / h1-6, 15-16H, 7-8H2. IKFAAYKFMPQDNX-UHFFFAOYSA-N. | |
| MOF&2,2'-Bipyridine, 4,4'-dimethoxy-, 1,1'-dioxide | MOF&2,2'-Bipyridine, 4,4'-dimethoxy-, 1,1'-dioxide. Group: Organic-linker blocks-bipyridine blocks. | |
| MOF&2,2'-Bipyridine]-4,4'-diol | MOF&2,2'-Bipyridine]-4,4'-diol. Group: Organic-linker blocks-bipyridine blocks. | |
| MOF&2,2'-Bipyridine, 5,5'-bis(bromomethyl)- | MOF&2,2'-Bipyridine, 5,5'-bis(bromomethyl)-. Group: Organic-linker blocks-bipyridine blocks. Product ID: 5-(bromomethyl)-2-[5-(bromomethyl)pyridin-2-yl]pyridine. Molecular formula: 342.03g/mol. Mole weight: C12H10Br2N2. InChI=1S/C12H10Br2N2/c13-5-9-1-3-11 (15-7-9)12-4-2-10 (6-14)8-16-12/h1-4, 7-8H, 5-6H2. OESAKGGTMNBXLT-UHFFFAOYSA-N. | |
| MOF&2-(2-carboxy-5-methylphenyl)-4-methylbenzoic Acid | MOF&2-(2-carboxy-5-methylphenyl)-4-methylbenzoic Acid. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Carboxylic acid mof ligand-dicarboxylic acid mof ligand. CAS No. 93012-36-3. Pack Sizes: 10 mg. Product ID: 2-(2-carboxy-5-methylphenyl)-4-methylbenzoic acid. Molecular formula: 270.28g/mol. Mole weight: C16H14O4. InChI=1S/C16H14O4/c1-9-3-5-11 (15 (17)18)13 (7-9)14-8-10 (2)4-6-12 (14)16 (19)20/h3-8H, 1-2H3, (H, 17, 18) (H, 19, 20). HCUNISHLIXGFFA-UHFFFAOYSA-N. | |
| MOF&2,3,6,7,10,11-Hexabromotriphenylene | MOF&2,3,6,7,10,11-Hexabromotriphenylene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-halide substituted aromatics. Pack Sizes: 8 mg. Product ID: 2,3,6,7,10,11-hexabromotriphenylene. Molecular formula: 701.7g/mol. Mole weight: C18H6Br6. InChI=1S/C18H6Br6/c19-13-1-7-8 (2-14 (13)20)10-4-17 (23)18 (24)6-12 (10)11-5-16 (22)15 (21)3-9 (7)11/h1-6H. GLHQUXLCQLQNPZ-UHFFFAOYSA-N. | |
| MOF&2,3'-Bipyridine, 1,1'-dioxide | MOF&2,3'-Bipyridine, 1,1'-dioxide. Group: Organic-linker blocks-bipyridine blocks. Product ID: 1-oxido-2-(1-oxidopyridin-1-ium-3-yl)pyridin-1-ium. Molecular formula: 188.18g/mol. Mole weight: C10H8N2O2. InChI=1S/C10H8N2O2/c13-11-6-3-4-9 (8-11)10-5-1-2-7-12 (10)14/h1-8H. SHNLJOWODFYYDR-UHFFFAOYSA-N. | |
| MOF&2,3-Diaminopyrazine | MOF&2,3-Diaminopyrazine. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks- other linker blocks. Pack Sizes: 16 mg. Product ID: pyrazine-2,3-diamine. Molecular formula: 110.12g/mol. Mole weight: C4H6N4. InChI=1S/C4H6N4/c5-3-4 (6)8-2-1-7-3/h1-2H, (H2, 5, 7) (H2, 6, 8). CAFSXVAFGILCCI-UHFFFAOYSA-N. | |
| MOF&2-(3-pyridinyl)-1H-Imidazole-4,5-dicarboxylic acid | MOF&2-(3-pyridinyl)-1H-Imidazole-4,5-dicarboxylic acid. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Carboxylic acid nitrogen-containing mixed mof ligand-multiple mixed ligand. CAS No. 51294-28-1. Pack Sizes: 50 mg. Product ID: 2-pyridin-3-yl-1H-imidazole-4,5-dicarboxylic acid. Molecular formula: 233.18g/mol. Mole weight: C10H7N3O4. InChI=1S/C10H7N3O4/c14-9 (15)6-7 (10 (16)17)13-8 (12-6)5-2-1-3-11-4-5/h1-4H, (H, 12, 13) (H, 14, 15) (H, 16, 17). HLANIEAGYFMGJV-UHFFFAOYSA-N. | |
| MOF&2,4-Pyridinedicarboxylic acid, 1-oxide | MOF&2,4-Pyridinedicarboxylic acid, 1-oxide. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Carboxylic acid mof ligand-dicarboxylic acid mof ligand. Pack Sizes: 10 mg. | |
| MOF&(2-(4-vinylphenyl)ethene-1,1,2-triyl)tribenzene | MOF&(2-(4-vinylphenyl)ethene-1,1,2-triyl)tribenzene. Group: Organic-linker blocks-1-substituted tpe. Pack Sizes: 10mL. Product ID: 1-ethenyl-4-(1,2,2-triphenylethenyl)benzene. Molecular formula: 358.5g/mol. Mole weight: C28H22. InChI=1S/C28H22/c1-2-22-18-20-26 (21-19-22) 28 (25-16-10-5-11-17-25) 27 (23-12-6-3-7-13-23) 24-14-8-4-9-15-24/h2-21H, 1H2. VDXVOUZXBSOCMM-UHFFFAOYSA-N. | |
| MOF&2,5-Diethynyl terephthalic acid | MOF&2,5-Diethynyl terephthalic acid. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Customizable mof linkers. Pack Sizes: 10 mg. | |
| MOF&2,5-Dioxo-1-pyrrolidinyl 4-(1,2,2-triphenylethenyl)benzoate | MOF&2,5-Dioxo-1-pyrrolidinyl 4-(1,2,2-triphenylethenyl)benzoate. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-1-substituted tpe. Pack Sizes: 50 mg. | |
| MOF&2,6,14-tribromo-9,10-dihydro-9,10-[1,2]benzenoanthracene | MOF&2,6,14-tribromo-9,10-dihydro-9,10-[1,2]benzenoanthracene. Group: Organic-linker blocks- other linker blocks. Product ID: 4, 11, 17-tribromopentacyclo[6.6.6.02, 7.09, 14.015, 20]icosa-2(7), 3, 5, 9(14), 10, 12, 15(20), 16, 18-nonaene. Molecular formula: 491.0g/mol. Mole weight: C20H11Br3. InChI=1S/C20H11Br3/c21-10-3-6-15-16 (7-10)19-13-4-1-11 (22)8-17 (13)20 (15)18-9-12 (23)2-5-14 (18)19/h1-9, 19-20H. JLTMUKRBITYDEG-UHFFFAOYSA-N. | |
| MOF&2,6-diiodo-1,3,5,7-tetramethyl-8H-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene | MOF&2,6-diiodo-1,3,5,7-tetramethyl-8H-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks- other linker blocks. Pack Sizes: 50 mg. | |
| MOF&2,6-Pyridinedimethanamine | MOF&2,6-Pyridinedimethanamine. Group: Organic-linker blocks- other linker blocks. Product ID: [6-(aminomethyl)pyridin-2-yl]methanamine. Molecular formula: 137.18g/mol. Mole weight: C7H11N3. InChI=1S/C7H11N3/c8-4-6-2-1-3-7 (5-9)10-6/h1-3H, 4-5, 8-9H2. SCAKSBRUOMUBFL-UHFFFAOYSA-N. | |
| MOF&2,9-dibromo-1,10-phenanthroline-5,6-dione | MOF&2,9-dibromo-1,10-phenanthroline-5,6-dione. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks- other linker blocks. Pack Sizes: 50mg. Product ID: 2,9-dibromo-1,10-phenanthroline-5,6-dione. Molecular formula: 367.98g/mol. Mole weight: C12H4Br2N2O2. InChI=1S/C12H4Br2N2O2/c13-7-3-1-5-9 (15-7)10-6 (12 (18)11 (5)17)2-4-8 (14)16-10/h1-4H. PVWHEXBKSREKSB-UHFFFAOYSA-N. | |
| MOF&2- (Bromomethyl) terephthalic acid | MOF&2- (Bromomethyl) terephthalic acid. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-triphenylbenzene. Pack Sizes: 50 mg. | |
| MOF&2-bromoterephthalicacid | MOF&2-bromoterephthalicacid. Group: Organic-linker blocks-terephthalics. Product ID: 2-bromoterephthalic acid. Molecular formula: 245.03g/mol. Mole weight: C8H5BrO4. InChI=1S/C8H5BrO4/c9-6-3-4 (7 (10)11)1-2-5 (6)8 (12)13/h1-3H, (H, 10, 11) (H, 12, 13). QPBGNSFASPVGTP-UHFFFAOYSA-N. | |
| MOF&2H-Tetrazole, 5-[4-(1H-1,2,4-triazol-1-yl)phenyl]- | MOF&2H-Tetrazole, 5-[4-(1H-1,2,4-triazol-1-yl)phenyl]-. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Nitrogen-containing mof ligand-binary nitrogen-containing mof ligand. CAS No. 1423810-54-1. Pack Sizes: 10 mg. | |
Our database is helping our users find suppliers everyday.
